Back
Summit Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
SMMT
Summit Therapeutics, Inc.
Last Price:
$16.20
Seasonality Move:
15.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Summit Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16 | Buy |
| 20-day SMA: | 15.26 | Buy |
| 50-day SMA: | 16.54 | Buy |
| 200-day SMA: | 20.56 | Sell |
| 8-day EMA: | 13.92 | Buy |
| 20-day EMA: | 8.83 | Buy |
| 50-day EMA: | 4.38 | Buy |
| 200-day EMA: | 1.23 | Buy |
Summit Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.46 | Buy |
| Relative Strength Index (14 RSI): | 57.09 | Buy |
| Chaikin Money Flow: | 2309694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.65 - 16.15) | Buy |
| Bollinger Bands (100): | (15.72 - 19.76) | Sell |
Summit Therapeutics, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics, Inc. Stock
Is Summit Therapeutics, Inc. Stock a Buy?
-
Summit Therapeutics, Inc. share price is 16.59 while SMMT 8-day simple moving average is 16.00, which is a Buy signal.
-
The stock price of SMMT is 16.59 while Summit Therapeutics, Inc. 20-day SMA is 15.26, which makes it a Buy.
-
Summit Therapeutics, Inc. 50-day simple moving average is 16.54 while SMMT share price is 16.59, making it a Buy technically.
-
SMMT stock price is 16.59 and Summit Therapeutics, Inc. 200-day simple moving average is 20.56, creating a Sell signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
34
Summit Therapeutics, Inc. (SMMT)
is a Sell
Is Summit Therapeutics, Inc. a Buy or a Sell?
-
Summit Therapeutics, Inc. stock is rated a SellThe current Summit Therapeutics, Inc. [SMMT] share price is $16.59. The Score for SMMT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics, Inc. Stock Info
Market Cap:
12.4B
Price in USD:
16.59
Share Volume:
2.4M
Summit Therapeutics, Inc. 52-Week Range
52-Week High:
36.91
52-Week Low:
13.83
Sell
34
Summit Therapeutics, Inc. (SMMT)
is a Sell
Summit Therapeutics, Inc. Share Price Forecast
-
What is the Summit Therapeutics, Inc. stock price today?The Summit Therapeutics, Inc. stock price is 16.59 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics, Inc. is overvalued.
Is Summit Therapeutics, Inc. Stock a Buy?
-
Summit Therapeutics, Inc. share price is 16.59 while SMMT 8-day exponential moving average is 13.92, which is a Buy signal.
-
The stock price of SMMT is 16.59 while Summit Therapeutics, Inc. 20-day EMA is 8.83, which makes it a Buy.
-
Summit Therapeutics, Inc. 50-day exponential moving average is 4.38 while SMMT share price is 16.59, making it a Buy technically.
-
SMMT stock price is 16.59 and Summit Therapeutics, Inc. 200-day simple moving average is 1.23, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics, Inc.
Is Summit Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.10 per share, and an increase next year of $0.01 per share.
Technical Analysis of Summit Therapeutics, Inc.
Should I short Summit Therapeutics, Inc. stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is 4.46, suggesting Summit Therapeutics, Inc. is a Buy
-
Summit Therapeutics, Inc. Relative Strength Index (RSI) is 57.09, which suggest Summit Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Summit Therapeutics, Inc. is (14.65 - 16.15), which suggest Summit Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics, Inc. is (15.72 - 19.76), which suggest Summit Therapeutics, Inc. is a Sell
* Summit Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.